Global Eflornithine Cream Market Research Report 2024

Publication ID:

PB510246405

Publication Date:

October 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Eflornithine cream, is a topical treatment used to reduce excessive facial hair growth in women with idiopathic hirsutism. It contains eflornithine hydrochloride, which inhibits the enzyme ornithine decarboxylase, thereby slowing hair growth.
The global Eflornithine Cream market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The development of Eflornithine cream has evolved significantly since its initial approval for treating facial hirsutism. Originally, the focus was on its novel mechanism of action, which inhibits the enzyme ornithine decarboxylase to reduce hair growth. Over time, research has centered on optimizing the cream鈥檚 formulation to enhance its effectiveness and minimize side effects, leading to improvements in its stability and patient tolerance.
Currently, the trend in Eflornithine cream development includes exploring its potential applications beyond facial hirsutism. Researchers are investigating its use for other forms of unwanted hair growth and related dermatological conditions. Additionally, advancements in drug delivery systems are being pursued to improve the cream's penetration and efficacy, potentially expanding its therapeutic indications.
Looking ahead, personalized medicine is expected to play a crucial role in the future development of Eflornithine cream. Tailoring treatments based on individual genetic and hormonal profiles could lead to more precise and effective interventions. Furthermore, integrating Eflornithine cream into combination therapies with other dermatological treatments may offer comprehensive solutions for managing hair growth disorders, reflecting a broader trend towards customized and multi-faceted approaches in dermatological care.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eflornithine Cream, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eflornithine Cream.
The Eflornithine Cream market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Eflornithine Cream market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eflornithine Cream manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol Myers Squibb
Derma Pella Pharmaceuticals
Almirall
Cipher Pharmaceuticals
Allergan
SkinMedica Pharmaceuticals
Actiza Pharmaceutical
Lotus International
Incepta Pharmaceuticals
Sun Pharma
Kavya Pharm
Segment by Type
11.5% Eflornithine Hydrochloride
13.9% Eflornithine Hydrochloride
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eflornithine Cream manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eflornithine Cream in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Eflornithine Cream Market Overview
1.1 Product Definition
1.2 Eflornithine Cream by Type
1.2.1 Global Eflornithine Cream Market Value Comparison by Type (2024-2030)
1.2.2 11.5% Eflornithine Hydrochloride
1.2.3 13.9% Eflornithine Hydrochloride
1.3 Eflornithine Cream by Application
1.3.1 Global Eflornithine Cream Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Eflornithine Cream Market Size Estimates and Forecasts
1.4.1 Global Eflornithine Cream Revenue 2019-2030
1.4.2 Global Eflornithine Cream Sales 2019-2030
1.4.3 Global Eflornithine Cream Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eflornithine Cream Market Competition by Manufacturers
2.1 Global Eflornithine Cream Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eflornithine Cream Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eflornithine Cream Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Eflornithine Cream, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eflornithine Cream, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eflornithine Cream, Product Type & Application
2.7 Global Key Manufacturers of Eflornithine Cream, Date of Enter into This Industry
2.8 Global Eflornithine Cream Market Competitive Situation and Trends
2.8.1 Global Eflornithine Cream Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Eflornithine Cream Players Market Share by Revenue
2.8.3 Global Eflornithine Cream Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Eflornithine Cream Market Scenario by Region
3.1 Global Eflornithine Cream Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eflornithine Cream Sales by Region: 2019-2030
3.2.1 Global Eflornithine Cream Sales by Region: 2019-2024
3.2.2 Global Eflornithine Cream Sales by Region: 2025-2030
3.3 Global Eflornithine Cream Revenue by Region: 2019-2030
3.3.1 Global Eflornithine Cream Revenue by Region: 2019-2024
3.3.2 Global Eflornithine Cream Revenue by Region: 2025-2030
3.4 North America Eflornithine Cream Market Facts & Figures by Country
3.4.1 North America Eflornithine Cream Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eflornithine Cream Sales by Country (2019-2030)
3.4.3 North America Eflornithine Cream Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eflornithine Cream Market Facts & Figures by Country
3.5.1 Europe Eflornithine Cream Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eflornithine Cream Sales by Country (2019-2030)
3.5.3 Europe Eflornithine Cream Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eflornithine Cream Market Facts & Figures by Region
3.6.1 Asia Pacific Eflornithine Cream Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eflornithine Cream Sales by Region (2019-2030)
3.6.3 Asia Pacific Eflornithine Cream Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Eflornithine Cream Market Facts & Figures by Country
3.7.1 Latin America Eflornithine Cream Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eflornithine Cream Sales by Country (2019-2030)
3.7.3 Latin America Eflornithine Cream Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Eflornithine Cream Market Facts & Figures by Country
3.8.1 Middle East and Africa Eflornithine Cream Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eflornithine Cream Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eflornithine Cream Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eflornithine Cream Sales by Type (2019-2030)
4.1.1 Global Eflornithine Cream Sales by Type (2019-2024)
4.1.2 Global Eflornithine Cream Sales by Type (2025-2030)
4.1.3 Global Eflornithine Cream Sales Market Share by Type (2019-2030)
4.2 Global Eflornithine Cream Revenue by Type (2019-2030)
4.2.1 Global Eflornithine Cream Revenue by Type (2019-2024)
4.2.2 Global Eflornithine Cream Revenue by Type (2025-2030)
4.2.3 Global Eflornithine Cream Revenue Market Share by Type (2019-2030)
4.3 Global Eflornithine Cream Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eflornithine Cream Sales by Application (2019-2030)
5.1.1 Global Eflornithine Cream Sales by Application (2019-2024)
5.1.2 Global Eflornithine Cream Sales by Application (2025-2030)
5.1.3 Global Eflornithine Cream Sales Market Share by Application (2019-2030)
5.2 Global Eflornithine Cream Revenue by Application (2019-2030)
5.2.1 Global Eflornithine Cream Revenue by Application (2019-2024)
5.2.2 Global Eflornithine Cream Revenue by Application (2025-2030)
5.2.3 Global Eflornithine Cream Revenue Market Share by Application (2019-2030)
5.3 Global Eflornithine Cream Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb Eflornithine Cream Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Derma Pella Pharmaceuticals
6.2.1 Derma Pella Pharmaceuticals Company Information
6.2.2 Derma Pella Pharmaceuticals Description and Business Overview
6.2.3 Derma Pella Pharmaceuticals Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Derma Pella Pharmaceuticals Eflornithine Cream Product Portfolio
6.2.5 Derma Pella Pharmaceuticals Recent Developments/Updates
6.3 Almirall
6.3.1 Almirall Company Information
6.3.2 Almirall Description and Business Overview
6.3.3 Almirall Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Almirall Eflornithine Cream Product Portfolio
6.3.5 Almirall Recent Developments/Updates
6.4 Cipher Pharmaceuticals
6.4.1 Cipher Pharmaceuticals Company Information
6.4.2 Cipher Pharmaceuticals Description and Business Overview
6.4.3 Cipher Pharmaceuticals Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipher Pharmaceuticals Eflornithine Cream Product Portfolio
6.4.5 Cipher Pharmaceuticals Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Company Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Allergan Eflornithine Cream Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 SkinMedica Pharmaceuticals
6.6.1 SkinMedica Pharmaceuticals Company Information
6.6.2 SkinMedica Pharmaceuticals Description and Business Overview
6.6.3 SkinMedica Pharmaceuticals Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SkinMedica Pharmaceuticals Eflornithine Cream Product Portfolio
6.6.5 SkinMedica Pharmaceuticals Recent Developments/Updates
6.7 Actiza Pharmaceutical
6.7.1 Actiza Pharmaceutical Company Information
6.7.2 Actiza Pharmaceutical Description and Business Overview
6.7.3 Actiza Pharmaceutical Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Actiza Pharmaceutical Eflornithine Cream Product Portfolio
6.7.5 Actiza Pharmaceutical Recent Developments/Updates
6.8 Lotus International
6.8.1 Lotus International Company Information
6.8.2 Lotus International Description and Business Overview
6.8.3 Lotus International Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lotus International Eflornithine Cream Product Portfolio
6.8.5 Lotus International Recent Developments/Updates
6.9 Incepta Pharmaceuticals
6.9.1 Incepta Pharmaceuticals Company Information
6.9.2 Incepta Pharmaceuticals Description and Business Overview
6.9.3 Incepta Pharmaceuticals Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Incepta Pharmaceuticals Eflornithine Cream Product Portfolio
6.9.5 Incepta Pharmaceuticals Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Company Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Pharma Eflornithine Cream Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Kavya Pharm
6.11.1 Kavya Pharm Company Information
6.11.2 Kavya Pharm Description and Business Overview
6.11.3 Kavya Pharm Eflornithine Cream Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kavya Pharm Eflornithine Cream Product Portfolio
6.11.5 Kavya Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eflornithine Cream Industry Chain Analysis
7.2 Eflornithine Cream Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eflornithine Cream Production Mode & Process
7.4 Eflornithine Cream Sales and Marketing
7.4.1 Eflornithine Cream Sales Channels
7.4.2 Eflornithine Cream Distributors
7.5 Eflornithine Cream Customers
8 Eflornithine Cream Market Dynamics
8.1 Eflornithine Cream Industry Trends
8.2 Eflornithine Cream Market Drivers
8.3 Eflornithine Cream Market Challenges
8.4 Eflornithine Cream Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bristol Myers Squibb
Derma Pella Pharmaceuticals
Almirall
Cipher Pharmaceuticals
Allergan
SkinMedica Pharmaceuticals
Actiza Pharmaceutical
Lotus International
Incepta Pharmaceuticals
Sun Pharma
Kavya Pharm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂